SCHEMBL66852

SCHEMBL66852

[O]CCCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL94890 0.90
SCHEMBL1008881 0.87 TSHR (0.75)
SCHEMBL821656 0.87 TSHR (0.75)
SCHEMBL1006395 0.87 TSHR (0.75)
SCHEMBL95801 0.87
SCHEMBL1008155 0.87 TSHR (0.75)
SCHEMBL1006840 0.87 TSHR (0.75)
SCHEMBL95166 0.87 TSHR (0.75)
SCHEMBL1007211 0.87 TSHR (0.75)
SCHEMBL1006545 0.87 TSHR (0.75)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2005 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118284669-A Asphalt composition comprising asphaltenes and epoxy-functionalized ethylene copolymers 陶氏环球技术有限责任公司 2024-07-02 CN claimed
US-20220402897-A1 CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE HOFFMANN-LA ROCHE INC. (US) 2022-12-22 US claimed
CN-112839714-A Chromen-4-one derivatives for the treatment and prevention of hepatitis B virus diseases 豪夫迈·罗氏有限公司 2021-05-25 CN claimed
US-10968198-B2 Biaryltriazole inhibitors of macrophage migration inhibitory factor YALE UNIVERSITY (US) 2021-04-06 US claimed
CN-107820496-B Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prevention of hepatitis B virus infections 豪夫迈·罗氏有限公司 2020-11-03 CN claimed
CN-107624113-B Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of HBsAg (HBV surface antigen) and HBV DNA production for the treatment of hepatitis B virus infection 豪夫迈·罗氏有限公司 2020-10-23 CN claimed
EP-3267794-B1 BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR UNIV YALE (US) 2020-09-09 EP claimed
CN-111247415-A Refractive index matching formulation 生命科技股份有限公司 2020-06-05 CN claimed
WO-2020079106-A1 CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-04-23 WO claimed
US-20190276425-A1 BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR UNIV YALE (US) 2019-09-12 US claimed
EP-0712388-A1 USE OF PHENOLS AND PHENOL DERIVATES AS MEDICAMENTS WITH FIBRINOGEN-REDUCING EFFECT Roche Diagnostics GmbH (DE) 1996-05-22 EP claimed
EP-0676396-A1 Tetrazolylphenyl pivalate derivatives and medicinal composition containing the same as effective component Wakamoto Pharmaceutical Co., Ltd. (JP) 1995-10-11 EP claimed
US-5430130-A Photosensitive polyfunctional aromatic diazo compounds useful in photosensitive compositions TOYO GOSEI KOGYO CO., LTD. (JP) 1995-07-04 US claimed
US-5395742-A IMAGEWISE EXPOSURE OF A PHOTOGRAPHIC MATERIAL TO LIGHT FUJI PHOTO FILM CO., LTD. (JP) 1995-03-07 US claimed
WO-1995005358-A1 USE OF PHENOLS AND PHENOL DERIVATES AS MEDICAMENTS WITH FIBRINOGEN-REDUCING EFFECT BOEHRINGER MANNHEIM GMBH (DE) 1995-02-23 WO claimed
EP-0626374-A2 A diaminostilbene series compound and a method for forming an image using the same FUJI PHOTO FILM CO., LTD. (JP) 1994-11-30 EP claimed
EP-0454501-A2 Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides Sankyo Company Limited (JP) 1991-10-30 EP claimed
EP-0123902-B1 PROCEDURE FOR THE DETERMINATION OF PEROXIDASE ACTIVITY BY END DILUTION TITRATION AND MEANS FOR ITS REALIZATION Byk-Sangtec Diagnostica GmbH &amp; Co. KG (DE) 1991-09-18 EP claimed
EP-0036730-B1 BICYCLOOCTANE DERIVATIVES, PROCESSES FOR PRODUCING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THEIR USE AS PHARMACEUTICALS AND PRECURSORS THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-01-02 EP claimed
EP-0123902-A2 Procedure for the determination of peroxidase activity by end dilution titration and means for its realization Byk-Sangtec Diagnostica GmbH &amp; Co. KG (DE) 1984-11-07 EP claimed